MENALCOL 0.5 ml/99.5 ml Topical Solution
Prescription review online
A doctor will review your case and decide whether a prescription is medically appropriate.
Talk to a doctor about this medicine
Discuss your symptoms and possible next steps in a quick online consultation.
How to use MENALCOL REFORZADO 70º CUTANEOUS SOLUTION
Contents of the leaflet
- Introduction
- What Menalcol Reinforced 70º is and what it is used for
- What you need to know before starting to use Menalcol Reinforced 70º
- How to Use Menalcol Reinforced 70º
- Possible Side Effects
- Storage of Menalcol Reinforced 70º
- Package Contents and Additional Information
Introduction
Package Leaflet: Information for the User
Menalcol Reinforced 70º Cutaneous Solution
Alcohol 70º/ Chlorhexidine Digluconate
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
- Keep this package leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. See section 4.
- You should consult a doctor if it worsens or does not improve after 2 days.
Contents of the Package Leaflet
- What Menalcol Reinforced 70º is and what it is used for
- What you need to know before starting to use Menalcol Reinforced 70º
- How to use Menalcol Reinforced 70º
- Possible side effects
- Storage of Menalcol Reinforced 70º
- Package Contents and Additional Information
1. What Menalcol Reinforced 70º is and what it is used for
Skin antiseptic.
You should consult a doctor if it worsens or does not improve after 2 days.
Not sure if this medicine is right for you?
Discuss your symptoms and treatment with a doctor online.
2. What you need to know before starting to use Menalcol Reinforced 70º
Do not use Menalcol Reinforced 70º
If you are allergic to the active ingredients of this medication (listed in section 6).
Do not apply to deep and extensive wounds, or mucous membranes.
Warnings and Precautions
Consult your doctor, pharmacist, or nurse before starting to use Menalcol Reinforced 70º.
Protect from heat. Highly flammable. Keep the container tightly closed.
Do not smoke during application.
Do not come into contact with mucous membranes.
Prolonged use may cause skin irritation and dryness.
May cause contact dermatitis.
Do not apply to wounds, as it can irritate damaged tissue and form a scab that protects resistant bacteria.
Menalcol Reinforced 70º cutaneous solution should not come into contact with the eyes due to the risk of visual damage. If it comes into contact with the eyes, wash immediately and abundantly with water. In case of irritation, redness, or eye pain, or visual disturbances, consult a doctor immediately.
Severe cases of persistent corneal injury (injury to the surface of the eye) that may require a corneal transplant have been reported when similar products have accidentally come into contact with the eyes during surgical interventions, in patients under general anesthesia (deep sleep induced without pain).
The solution is flammable.
The risk of fire is high when using an ignition source (electrosurgical units, lasers, fiber optic light sources, high-speed drills...) in combination with a combustion source (such as cloths, towels...) and an oxidizing agent (oxygen, air, nitrous oxide...).
To reduce the risk of fire:
- Do not use electrocautery procedures or other ignition sources until the skin is completely dry.
- Remove any soaked material, gauze, or gowns before starting the intervention.
- Do not use excessive amounts and avoid accumulating the solution in skin folds, under the patient, or soaking sheets or other materials in direct contact with the patient.
- When applying an occlusive dressing to areas previously exposed to Menalcol Reinforced 70º, take special care to ensure there is no excess product before applying the dressing.
- Reduce oxygen supply or any other oxidizing agent to the minimum necessary. Those procedures performed on the head, neck, and upper chest (above T5) and the use of an ignition source near an oxidizing agent put the patient at risk of suffering a surgical fire.
Children
Use with caution in neonates, especially those born before 32 weeks of gestation and in the first 2 weeks of life. Menalcol Reinforced 70º may cause chemical burns to the skin.
Do not use high amounts and avoid accumulating the solution in skin folds, under the patient, or soaking sheets or other moist materials in direct contact with the patient.
Pregnancy
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and Using Machines
The influence of this medication on the ability to drive and use machines is nil or insignificant.
3. How to Use Menalcol Reinforced 70º
Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
For cutaneous use. For external use only. DO NOT INGEST.
Apply directly to the area to be treated, let it act for 2 minutes before any procedure.
It is recommended to wash your hands after each application.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
If you use more Menalcol Reinforced 70º than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Started taking the medicine and have questions?
Discuss your symptoms and treatment with a doctor online.
4. Possible Side Effects
Like all medications, this medication can cause side effects, although not everyone experiences them.
Prolonged use may cause skin irritation and dryness.
Other possible side effects, for which the frequency is unknown, are:
- Corneal injury (injury to the surface of the eye) and permanent eye injury, including permanent visual impairment (after accidental eye exposure during surgical interventions in the head, face, and neck) in patients under general anesthesia (deep sleep induced without pain).
Reporting Side Effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that is not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medication.
5. Storage of Menalcol Reinforced 70º
Keep this medication out of sight and reach of children.
Flammable. Avoid exposing the bottle and its contents to open flames during use, storage, and disposal of the product.
Do not store at high temperatures, as it is highly flammable. Store in the original package to protect it from light.
Do not use this medication after the expiration date shown on the package. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This will help protect the environment.
6. Package Contents and Additional Information
Composition of Menalcol Reinforced 70º:
The active ingredients are ethanol 70% (alcohol 70º) and chlorhexidine digluconate.
Each ml of solution contains 0.995 ml of ethanol at 70% (alcohol 70º) and 0.005 ml of chlorhexidine digluconate.
Each 100 ml of solution contains 99.5 ml of ethanol at 70% (alcohol 70º) and 0.5 ml of chlorhexidine digluconate.
It has no other components (excipients).
Appearance of the Product and Package Contents
Clear, transparent cutaneous solution.
It comes in a 250 ml transparent polyethylene bottle with a cap and seal.
Additional Information
In the absence of compatibility studies, this medication should not be mixed with others.
Marketing Authorization Holder and Manufacturer
LABORATORIO REIG JOFRE, S.A.
Gran Capitán, 10
08970 Sant Joan Despí (Barcelona)
Date of the Last Revision of this Package Leaflet: July 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
- Country of registration
- Dosage formTOPICAL SOLUTION, 0.5 ml / 99.5 ml
- ATC codeD08AC52
- Availability in pharmaciesSupply issue reported
- Active substance
- Prescription requiredNo
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MENALCOL REFORZADO 70º CUTANEOUS SOLUTIONDosage form: TOPICAL SOLUTION, 20 mg/ml + 0.70 ml/mlActive substance: chlorhexidine, combinationsManufacturer: Vesismin S.L.U.Prescription not requiredDosage form: TOPICAL SOLUTION, 20 mg/ml + 0.70 ml/mlActive substance: chlorhexidine, combinationsManufacturer: Vesismin S.L.U.Prescription not requiredDosage form: TOPICAL SOLUTION, 20 mg/ml + 0.7 ml/mlActive substance: chlorhexidine, combinationsManufacturer: Becton Dickinson FrancePrescription not required
Online doctors for MENALCOL REFORZADO 70º CUTANEOUS SOLUTION
Discuss questions about MENALCOL REFORZADO 70º CUTANEOUS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get MENALCOL REFORZADO 70º CUTANEOUS SOLUTION Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
MENALCOL REFORZADO 70º CUTANEOUS SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in MENALCOL REFORZADO 70º CUTANEOUS SOLUTION is chlorhexidine, combinations. This information helps identify medicines with the same composition but different brand names.
MENALCOL REFORZADO 70º CUTANEOUS SOLUTION is manufactured by Laboratorio Reig Jofre, S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MENALCOL REFORZADO 70º CUTANEOUS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy MENALCOL REFORZADO 70º CUTANEOUS SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (chlorhexidine, combinations) include BACTISEPTIC PHARMA 20 mg/mL + 0.70 mL/mL CUTANEOUS SOLUTION, BACTISEPTIC PHARMA ORANGE 20 mg/mL + 0.70 mL/mL CUTANEOUS SOLUTION, CHLORAPREP ORANGE 20mg/ml + 0.70 ml/ml CUTANEOUS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
